News

Latest news

15th November 2024

Newton Biocapital announces its first investment in Japan from its “Newton Biocapital Partners II” fund to Japanese drug discovery startup, Tensegrity Pharma

14th November 2024

ニュートンバイオキャピタル、日本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、日本初の投資を発表

13th November 2024

French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance

22nd October 2024

当社のご紹介 2024年10月

22nd October 2024

創薬のプリズムバイオラボに熱視線　メガファーマも評価（日本経済新聞掲載）

22nd October 2024

EPICS Therapeutics Appoints Graeme Fraser PhD, Chief Executive Officer and Raises €12M in Series A Preferred Financing to Advance its Oncology Pipeline

23rd September 2024

SYNERGIA MEDICAL SUCCESSFULLY IMPLANTS FIRST PATIENTS WITH NAO.VNS(TM)

東京証券取引所グロース市場への上場承認に関するお知らせ

Presentation of the main results of the phase 2/3 ACTISAVE study in the treatment of stroke at ESOC 2024

1
2
3